QSV Equity Investors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$938K Sell
2,192
-842
-28% -$367K 1.39% 27
2025
Q3
$1.36M Buy
3,034
+2,524
+495% +$1.14M 1.39% 33
2025
Q2
$248K Buy
510
+2
+0.4% +$1.14K 0.26% 82
2025
Q1
$313K Sell
508
-3
-0.6% -$1.71K 0.32% 70
2024
Q4
$271K Buy
511
+2
+0.4% +$1.13K 0.26% 75
2024
Q3
$306K Hold
509
0.29% 74
2024
Q2
$276K Sell
509
-75
-13% -$43K 0.29% 70
2024
Q1
$375K Hold
584
0.36% 67
2023
Q4
$341K Buy
+584
New +$327K 0.33% 72

Other funds holding CHE

QSV Equity Investors's CHE Position: Q4 2025 in Review

QSV Equity Investors reduced its Chemed (CHE) stake by 28% in Q4 2025, selling an estimated $367K and leaving 2,192 shares worth $938K. The position accounts for 1.39% of the portfolio, ranked #27.

QSV Equity Investors first reported a position in CHE in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.36M in Q3 2025. 517 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • QSV Equity Investors held 2,192 shares of Chemed worth $938K as of Q4 2025.
  • QSV Equity Investors sold 842 Chemed shares in Q4 2025, an estimated $367K.
  • Chemed made up 1.39% of QSV Equity Investors's portfolio in Q4 2025, its #27 holding.
  • QSV Equity Investors first reported a position in Chemed in Q4 2023 and has held it in 9 quarters since.
  • QSV Equity Investors's Chemed position peaked at $1.36M in Q3 2025.
  • 517 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.